טוען...

Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension

Although inhaled NO (iNO) therapy is often effective in treating infants with persistent pulmonary hypertension of the newborn (PPHN), up to 40% of patients fail to respond, which may be partly due to abnormal expression and function of soluble guanylate cyclase (sGC). To determine whether altered s...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Chester, Marc, Seedorf, Gregory, Tourneux, Pierre, Gien, Jason, Tseng, Nancy, Grover, Theresa, Wright, Jason, Stasch, Johannes-Peter, Abman, Steven H.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Physiological Society 2011
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3213988/
https://ncbi.nlm.nih.gov/pubmed/21856817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajplung.00138.2010
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!